ZELIRA THERAPEUTICS LTD. financial statements, including revenue, expenses, profit, and loss
The total revenue of G1G for the last semiannual is 25.04 k EUR, and it's 25.82% lower compared to the previous semiannual. The net income of H2 24 is -1.51 M EUR.